WHO ICTRP trial
A multi-centre randomized double blind 12-week study to assess the efficacy…
EUCTR2012-003347-30-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-003347-30-HU |
|---|---|
| Public title | A multi-centre randomized double blind 12-week study to assess the efficacy, safety and tolerability of QVA149 in patients with COPD who have moderate to severe airflow limitation |
| Scientific title | A 12-week treatment, multi-center, randomized, double-blind, parallel group, placebo and active controlled study to assess the efficacy, safety, and tolerability of QVA149 (indacaterol maleate /glycopyrronium bromide) in COPD patients with moderate to severe airflow limitation |
| Primary sponsor | Novartis Pharma Services AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | France;Egypt;United States;Panama;Venezuela, Bolivarian Republic of;Hungary;Mexico;Slovenia;Slovakia;Argentina;Guatemala;Colombia |
| Conditions | Chronic Obstructive Pulmonary Disease (COPD) MedDRA version: 14.1 Level: LLT Classification code 10010952 Term: COPD System Organ Class: 100000004855 ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] |
| Interventions | Product Name: Indacaterol maleate/Glycopyrronium bromide Product Code: QVA149 Pharmaceutical Form: Inhalation powder, hard capsule INN or Proposed INN: GLYCOPYRRONIUM BROMIDE CAS Number: 596-51-0 Current Sponsor code: NVA237 Concentration… |
| Registration date | Apr 1, 2013 |
| Target size | 1000 |
| Secondary IDs | CQVA149A2337 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: